Order

Size
Price
Stock
Qty

GSK 690693

Axon 1729
CAS:  937174-76-0
  • Optical Purity:  Optically pure
  • Soluble in DMSO
  • MF:  C21H27N7O3
  • MW:  425.48

Description

GSK 690693 is a potent ATP-competitive Akt kinase inhibitor with IC50 values of 2 nM for Akt1, 13 nM for Akt2 and 9 nM for Akt3.

Akt isoforms integrate PI3K pathway signaling to control growth, metabolism, survival and apoptosis. GSK 690693 is useful for pan-Akt pathway inhibition and isoform-sensitive kinase pharmacology.

Key Features

  • Potent ATP-competitive Akt inhibitor
  • IC50: 2 nM for Akt1, 13 nM for Akt2 and 9 nM for Akt3
  • Targets all three Akt isoforms
  • Useful reference for PI3K/Akt pathway blockade

Applications

  • Akt kinase assay development
  • PI3K/Akt signaling research
  • Cancer cell survival studies
  • Isoform and pathway selectivity profiling

More Information

Certificate of Analysis

Material Safety Data Sheet

Parent CAS No. 937174-76-0
Chemical Name (S)-4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
SMILES N1C(C#CC(C)(C)O)=C2N=C(C3C(N)=NON=3)N(CC)C2=C(OC[C@H]2CCCNC2)C=1 |&1:24,r|
MFCD N.A.
InChi InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1
InChiKey KGPGFQWBCSZGEL-ZDUSSCGKSA-N
CID 16725726
Short Description AKT inhibitor

Related Products

AXON ID NAME FROM PRICE
1239 Deguelin

From $121.00

1602 PF 4708671

From $121.00

1663 Perifosine

From $93.50

1684 MK 2206 dihydrochloride

From $88.00

1685 YS 49

From $148.50

1790 SC 66

From $77.00

1859 AZD5363 dihydrochloride

From $99.00

1870 PHT 427

From $82.50

1903 DG2

From $104.50

2166 AT 13148 dihydrochloride

From $77.00

2460 GSK 2110183 hydrochloride

From $115.50

2464 LY 2584702 tosylate

From $137.50

2507 SC 79

From $82.50

2540 Akt Inhibitor VIII

From $104.50

3343 ML-9 hydrochloride

From $66.00

3850 M2698

From Inquiry

3958 Uprosertib

From Inquiry

4037 GDC-0068

From Inquiry

Loading...